Asia / HONG KONG
Company Overview
HJ Science Co., Ltd. operates as a clinical-stage biotechnology that researches and develops innovative small-molecule drugs for autoimmune, metabolic, and oncology diseases. The company was founded in 2017 by Jian Xin Ji and is headquartered in Chengdu, China.
HJ Science Co., Ltd. operates as a clinical-stage biotechnology that researches and develops innovative small-molecule drugs for autoimmune, metabolic, and oncology diseases. The company was founded in 2017 by Jian Xin Ji and is headquartered in Chengdu, China.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Biological Products Exc. Diagnostic |
| Country | HONG KONG |
| Employees | 115 |
| Reporting Unit | Millions |
| Primary Exchange | HKG |
| Instrument Type | Equity |
| Wright ID | C344S8H05 |
Key Metrics
| Current price | $30.16 |
| Market cap | $2.22 B |
| P/E ratio | n/a |
| Common shares | 73.6 M |
| Share type | H Gu |
| Quality rating | DDD0 |
| Dividend yield | n/a |
Recent stock performance
| 1 Week | +12.5% |
| 4 Week | -15.7% |
| 13 Week | -25.5% |
Officers
n/a
Address
HONG KONG
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.